Public & Societal Benefit
(W20Z)
DRUG STRATEGIES
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$1.9M
Total Revenue
$375K
Total Expenses
N/A
Net Assets
1
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$117K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.9M | $375K | N/A | — | 1 |
| 2023 | $73K | $238K | N/A | — | 1 |
| 2022 | $182K | $284K | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.